Lakefront Biotherapeutics | GLPG - EPS Earnings Per Share


Lakefront Biotherapeutics reported EUR-0.84 in EPS Earnings Per Share for its fiscal quarter ending in March of 2026.


Fiscal Calendar Actual Consensus Previous Date
FY2026Q1 Mar/2026 0.21 -1.21 -2.35 May/06
FY2025Q4 Dec/2025 11.89 -0.17 0.29 Feb/23
FY2025Q3 Sep/2025 -3.07 -0.41 -0.74 Nov/05
FY2025Q1 Jun/2025 -1.58 -0.17 0.11 Jul/23
FY2025Q1 Mar/2025 -2.35 -0.16 0.36 Apr/23




Eps Change Date
argenx SE USD 4.7 2.1 Mar/2026
AstraZeneca USD 2.58 0.46 Mar/2026
Biogen USD 3.57 1.58 Mar/2026
Genmab DKK 3.69 2.77 Dec/2025
Gilead Sciences USD 2.03 0.17 Mar/2026
GlaxoSmithKline GBP 0.43 0.17 Mar/2026
GRIFOLS EUR 0.14 0.11 Mar/2026
Hikma Pharmaceutical USD 0.65 0.12 Dec/2025
Incyte USD 1.81 0.01 Mar/2026
Merck EUR 2.11 0.23 Mar/2026
Neurocrine Biosciences USD 1.94 0.06 Mar/2026
Novartis USD 1.99 0.04 Mar/2026
Roche Holding CHF 8.37 2.95 Dec/2025
Sanofi EUR 1.88 0.35 Mar/2026
UCB EUR 5.65 3.21 Dec/2025
Vertex Pharmaceuticals USD 4.47 0.56 Mar/2026